-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The two companies will conduct strategic cooperation in the development of all-human GPCR antibodies based on the antibody discovery platform of RenMab®, the world's most advanced all-human antibody mouse, and Libero Tera's outstanding antigen preparation technology, the company announced today.
the collaboration aims to find therapeutic all-human GPCR antibodies.
the agreement, the first phase of cooperation will jointly carry out anti-tumor antibody discovery for GPCR targets until the completion of the evaluation of drug llermic effectiveness in the body, to determine the lead antibody molecules.
Libero Thera is responsible for antigen preparation and participation in in vitro antibody screening, and Baiosaitu will use its RenMab® mouse platform to conduct GPCR antibody discovery and complete the screening of lead antibody candidate molecules through drug ability evaluation techniques in animals.
note: There are deletions in the original text